Alarming Scale of Multidrug-Resistant TB Requires Rapid Response
Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to...

Alarming Scale of Multidrug-Resistant TB Requires Rapid Response

Alarming new data suggest that the global scope of multidrug-resistant tuberculosis (MDR-TB) is much more vast than previously estimated, requiring a concerted international effort to combat this deadlier form of the disease, the international medical humanitarian organization Doctors Without Borders announced today.

“Wherever we look for drug resistant TB we are finding it in alarming numbers, suggesting current statistics may only be scratching the surface of the problem,” said MSF president Dr. Unni Karunakara. “And with 95 percent of TB patients worldwide lacking access to proper diagnosis, efforts to scale up detection of MDR-TB are being severely undermined by a retreat in donor funding— precisely when increased funding is needed most.”

Photo: India 2012 © Bithin Das
Some of the drugs, part of a long, difficult regimen, that MDR-TB patients must take